LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | AZD7762 | 0.37 | uM | LJP6 | 72 | hr | 765 | 565 | 3101 | 0.1824 | -0.1395 |
Hs 578T | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 765 | 829 | 3101 | 0.2677 | 0.0406 |
Hs 578T | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 765 | 2849 | 3101 | 0.9193 | 0.9179 |
Hs 578T | AZD7762 | 0.12 | uM | LJP6 | 72 | hr | 765 | 632 | 3101 | 0.2040 | -0.0903 |
Hs 578T | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 765 | 1121 | 3101 | 0.3617 | 0.2086 |
Hs 578T | AZD8055 | 1.11 | uM | LJP6 | 72 | hr | 765 | 1035 | 3101 | 0.3335 | 0.1601 |
Hs 578T | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 765 | 3110 | 3148 | 0.9880 | 0.9880 |
Hs 578T | Seliciclib | 10 | uM | LJP5 | 72 | hr | 765 | 2245 | 3148 | 0.7132 | 0.6947 |
Hs 578T | AT-7519 | 1.11 | uM | LJP6 | 72 | hr | 765 | 445 | 3101 | 0.1436 | -0.2353 |
Hs 578T | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 765 | 1116 | 3101 | 0.3600 | 0.2054 |
Hs 578T | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 765 | 466 | 3101 | 0.1504 | -0.2176 |
Hs 578T | AZD7762 | 10 | uM | LJP6 | 72 | hr | 765 | 315 | 3101 | 0.1015 | -0.3560 |
Hs 578T | AZD8055 | 0.12 | uM | LJP6 | 72 | hr | 765 | 1030 | 3101 | 0.3322 | 0.1585 |
Hs 578T | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 765 | 1078 | 3101 | 0.3474 | 0.1839 |
Hs 578T | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 765 | 3140 | 3148 | 0.9974 | 0.9974 |
Hs 578T | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 765 | 3161 | 3148 | 1.0043 | 1.0041 |
Hs 578T | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 765 | 3091 | 3148 | 0.9820 | 0.9818 |
Hs 578T | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 765 | 3092 | 3148 | 0.9823 | 0.9822 |
Hs 578T | AT-7519 | 0.12 | uM | LJP6 | 72 | hr | 765 | 2279 | 3101 | 0.7348 | 0.7168 |
Hs 578T | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 765 | 531 | 3101 | 0.1712 | -0.1659 |
Hs 578T | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 765 | 300 | 3101 | 0.0968 | -0.3718 |
Hs 578T | AT-7519 | 10 | uM | LJP6 | 72 | hr | 765 | 266 | 3101 | 0.0862 | -0.4158 |
Hs 578T | AZD7762 | 1.11 | uM | LJP6 | 72 | hr | 765 | 497 | 3101 | 0.1604 | -0.1920 |
Hs 578T | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 765 | 3596 | 3101 | 1.1593 | 1.1519 |
Hs 578T | AZD8055 | 10 | uM | LJP6 | 72 | hr | 765 | 510 | 3101 | 0.1650 | -0.1859 |